Description:Minmek-G2 combines Metformin HCL (Sustained Release) 500mg and Glimepiride 2mg to provide comprehensive management of type 2 diabetes. This dual-action formula combines sustained glucose control with enhanced insulin secretion for effective blood sugar regulation.Key Benefits:Metformin HCL (SR) 500mg: Offers extended-release action for prolonged blood sugar control and improved insulin sensitivityGlimepiride 2mg: Stimulates insulin release from the pancreas to help lower blood glucose levelsProvides balanced and sustained glucose managementReduces the risk of diabetes-related complicationsComposition:Metformin HCL (SR) 500mg: A sustained-release formulation that maintains effective blood sugar control throughout the dayGlimepiride 2mg: Enhances insulin secretion to better regulate blood sugar levelsRecommended Usage:Take 1 tablet daily with food or as prescribed by your healthcare provider. Adjust dosage based on individual blood sugar levels and response to treatment.
Reviews
There are no reviews yet.